Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01994759
Other study ID # H-2-2012-150-FJ
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date September 1, 2013
Est. completion date December 1, 2016

Study information

Verified date July 2018
Source Bispebjerg Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether reduced load to patients with plantar fasciitis (reduced standing, walking, landing) together with either controlled heavy resistance training or glucocorticosteroid injection or a combination thereof is the best treatment.


Description:

Plantar fasciitis (PF) is a frequently diagnosed condition, defined as pain at the medial tubercle of the calcaneus, and 10% of the population will at some points in their life experience this condition. Accumulated loading of the plantar fascia seems to relate to development of PF, as it is commonly seen in runners and those who are overweight, and number of daily steps or simply time of standing has been shown to be a predisposing factor for PF development.

Orthosis and glucocorticoid injections are 2 widely used treatments with proven effect. However treatment of overuse injury in other tendon/aponeurosis-like structures, has over the later years been dominated by an increasing documentation of a good curative effect of heavy controlled mechanical loading (eccentric strength exercises or heavy slow concentric strength training) upon tendinopathies in Achilles or patella tendon. However, no studies have looked at the influence of physical training (e.g. strength training) on the diseased plantar aponeurosis. Also no studies have looked at the effect of a combination of giving local glucocorticoid injection and training on this or other tendon overuse entities.

We hypothesize that heavy strength training will have a positive effect upon PF, and that a combination of training and glucocorticoid injections will have an additive effect upon this disease and be even more effective than each of the treatments alone. Glucocorticoid injection acting as the standard control treatment.


Recruitment information / eligibility

Status Completed
Enrollment 90
Est. completion date December 1, 2016
Est. primary completion date July 1, 2015
Accepts healthy volunteers No
Gender All
Age group 20 Years to 65 Years
Eligibility Inclusion Criteria:

- Pain at the medial attachment of fascia plantaris.

- First step pain in the morning

- Symptoms for at least 3 months.

- Age 20-65 years

- Ultrasound scanning at the first visit shows thickness of the fascia above 4 mm.

- Patient can read and understand danish

Exclusion Criteria:

- known arthritis, inflammatory bowl disease, psoriasis or clinical signs of any of these

- Leg ulcerations

- Longlasting oedema of the leg and foot

- Palpatory decreased puls in the foot

- Diabetes

- Reduced sensibility in the foot

- Infections in the foot

- Daily use of pain killers

- Pregnancy or planning to become pregnant

- Earlier operations on the foot, that is judged to complicate training

- Patient assessed not to be able to participate in the training for other reasons

- Glucocorticosteroid injection to the diseased plantar fascia within the last 6 months.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Training
Patients are instructed to carry out strengthening exercises for the fascia plantaris 3 days a week and stretching exercises every day. Four times in the first 2 months supervised training in groups is carried out with a physiotherapist supervising the exercises and instructing in progression and new exercises, and all participants are instructed to carry out a specific training program daily at home. The amount of training performed by each patient, is registered in a diary weekly
Drug:
Glucocorticosteroid injection
Ultra sound guided injection af 1 ml og Glucocorticosteroid (methylprednisolone 40 mg) and 1 ml of lidocaine 5mg/ml from the medial side profound to the thickened part of the fascia plantaris. Glucocorticosteroid injections are given every month until the aponeurosis thickness is less than 4 mm as determined by ultrasonography (max 3 injections).
Behavioral:
Reduction in impact
advocate reduction in standing, walking, running, jumping. advocate shock absorbing shoes advocate prefabricated insoles advocate taping in special occasions.

Locations

Country Name City State
Denmark Institute of Sports Medicine Copenhagen, Bispebjerg Hospital Kobenhavn

Sponsors (2)

Lead Sponsor Collaborator
Bispebjerg Hospital Fonden for Faglig Udvikling af Speciallægepraksis, Denmark

Country where clinical trial is conducted

Denmark, 

References & Publications (10)

Baldassin V, Gomes CR, Beraldo PS. Effectiveness of prefabricated and customized foot orthoses made from low-cost foam for noncomplicated plantar fasciitis: a randomized controlled trial. Arch Phys Med Rehabil. 2009 Apr;90(4):701-6. doi: 10.1016/j.apmr.2008.11.002. — View Citation

Cheng JW, Tsai WC, Yu TY, Huang KY. Reproducibility of sonographic measurement of thickness and echogenicity of the plantar fascia. J Clin Ultrasound. 2012 Jan;40(1):14-9. doi: 10.1002/jcu.20903. Epub 2011 Nov 22. — View Citation

Crawford F, Thomson C. Interventions for treating plantar heel pain. Cochrane Database Syst Rev. 2003;(3):CD000416. Review. Update in: Cochrane Database Syst Rev. 2010;(1):CD000416. — View Citation

Kongsgaard M, Kovanen V, Aagaard P, Doessing S, Hansen P, Laursen AH, Kaldau NC, Kjaer M, Magnusson SP. Corticosteroid injections, eccentric decline squat training and heavy slow resistance training in patellar tendinopathy. Scand J Med Sci Sports. 2009 Dec;19(6):790-802. doi: 10.1111/j.1600-0838.2009.00949.x. Epub 2009 May 28. — View Citation

Pfeffer G, Bacchetti P, Deland J, Lewis A, Anderson R, Davis W, Alvarez R, Brodsky J, Cooper P, Frey C, Herrick R, Myerson M, Sammarco J, Janecki C, Ross S, Bowman M, Smith R. Comparison of custom and prefabricated orthoses in the initial treatment of proximal plantar fasciitis. Foot Ankle Int. 1999 Apr;20(4):214-21. — View Citation

Radford JA, Landorf KB, Buchbinder R, Cook C. Effectiveness of low-Dye taping for the short-term treatment of plantar heel pain: a randomised trial. BMC Musculoskelet Disord. 2006 Aug 9;7:64. — View Citation

Roos E, Engström M, Söderberg B. Foot orthoses for the treatment of plantar fasciitis. Foot Ankle Int. 2006 Aug;27(8):606-11. — View Citation

Tobin L, Simonsen L, Bülow J. Real-time contrast-enhanced ultrasound determination of microvascular blood volume in abdominal subcutaneous adipose tissue in man. Evidence for adipose tissue capillary recruitment. Clin Physiol Funct Imaging. 2010 Nov;30(6):447-52. doi: 10.1111/j.1475-097X.2010.00964.x. Epub 2010 Aug 22. — View Citation

Uden H, Boesch E, Kumar S. Plantar fasciitis - to jab or to support? A systematic review of the current best evidence. J Multidiscip Healthc. 2011;4:155-64. doi: 10.2147/JMDH.S20053. Epub 2011 May 24. — View Citation

Vohra PK, Kincaid BR, Japour CJ, Sobel E. Ultrasonographic evaluation of plantar fascia bands. A retrospective study of 211 symptomatic feet. J Am Podiatr Med Assoc. 2002 Sep;92(8):444-9. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other patient diary 100 mm VAS score for morning pain (average in the week). 100 mm VAS score for pain at function (average in the week). Compliance to the treatment. Side effects to glucocorticosteroid injections is described. week 1,2,3,4,5,6,7,8,9,10,11,12,13
Other Contrast Enhanced Ultrasound For determining bloodflow of the plantar fascia we inject 2 ml SonoVue®. Ultrasound contrast agent, that amplifies the ultrasound signal. After injection we simultaneously ultrasound scan both feet for 3 minutes. The perfusion of the fascia can hereby bee calculated.
Only patients with unilateral plantar fasciitis will bee offered this evaluation.
at entry after 3-4 months and after 1 year
Primary 100 mm VAS score pain at function. Average pain during everyday living. 6 month
Primary Foot Function Index Foot function Index is a validated score for patients with plantar fasciitis. It consists of 23 questions concerning pain, function and impact on daily life. Each question is answered on a box scale 0-10, giving a score range: 0-230. 6 month
Secondary 100 mm VAS score for morning pain at entry, 3 month (after intervention), 6 month, 12 month, 24 month
Secondary Ultrasound scanning thickness measure measurement of the thickness of the thickest part of the fascia by B-mode Ultrasound scanning at entry, 3 month (after intervention), 6 month, 12 month, 24 month
Secondary 100 mm VAS score pain at function. Average pain during everyday living. 3 months, 12 months, 24 months
Secondary Foot Function Index Foot function Index is a validated score for patients with plantar fasciitis. It consists of 23 questions concerning pain, function and impact on daily life. Each question is answered on a box scale 0-10, giving a score range: 0-230. 3 month, 12 month, 24 month
See also
  Status Clinical Trial Phase
Completed NCT02546115 - RCT - Assessing the Benefits of the Use of a Tension Night Splint in Patients With Plantar Fasciitis N/A
Terminated NCT01996111 - Dehydrated Human Amnion/Chorion Membrane Micrografts(dHACM) Injectable in the Treatment of Recalcitrant Plantar Fasciitis N/A
Unknown status NCT01882894 - Efficacy of a Custom Temporary Foot Orthosis for Plantar Fasciitis Treatment N/A
Completed NCT01659827 - Comparative Study of Amniotic Membrane Injectable in the Treatment of Recalcitrant Plantar Fasciitis N/A
Completed NCT00888394 - Effectiveness of Podiatry on Plantar Pain Phase 4
Completed NCT00758641 - Platelet Rich Plasma to Treat Plantar Fasciitis Phase 4
Terminated NCT00527748 - Foot and Ankle Range of Motion (Stretching) Apparatus N/A
Recruiting NCT05584046 - A Single-blind RCT to Investigate the Effect of a Novel Herbal Patch for the Treatment of PF N/A
Completed NCT04088383 - Amnios™ RT Outcomes Study N/A
Completed NCT02646579 - Effects of Dry Needling Using Spinal and Peripheral Sites Versus Peripheral Sites Only N/A
Completed NCT05592808 - Comparison of Taping Techniques in Plantar Fasciitis N/A
Not yet recruiting NCT04125264 - Intense Therapeutic Ultrasound (ITU) to Treat Plantar Fasciitis N/A
Completed NCT02546089 - ABI v Dry Needling for Plantar Fasciitis N/A
Completed NCT00765843 - A Trial of Custom Foot Orthoses for the Treatment of Plantar Heel Pain N/A
Completed NCT00155324 - Change and Clinical Significance of Plantar Fascia Thickness After ESWT N/A
Completed NCT04941469 - Effectiveness of Specifically Optimized Off-the-counter Foot Orthosis for the Subtle Cavus Foot N/A
Completed NCT06055933 - Effect of Kinesio Taping and Extracorporeal Shock Wave Therapy on Plantar Fasciitis
Recruiting NCT02539082 - the Safety and Efficacy of Collagen Injection in Patients With Plantar Fasciitis Phase 4
Enrolling by invitation NCT01786057 - Effect of Extracorporeal Shock Wave Therapy of Gastrosoleus Trigger Points in Patients With Plantar Fasciitis Phase 2/Phase 3
Recruiting NCT03978234 - Evaluating the Safety and Effect of abobotulinumtoxinA in the Gastrocnemius Muscle to Improve Equinus and Plantar Fasciitis Pain Phase 2